Courtney M. Shirley, Ph.D. - Publications

Affiliations: 
2012 Johns Hopkins University, Baltimore, MD 
Area:
Virology Biology, Pharmacology, Oncology

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhu R, Shirley CM, Chu SH, Li L, Nguyen BH, Seo J, Wu M, Seale T, Duffield AS, Staudt LM, Levis M, Hu Y, Small D. Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition. Leukemia. PMID 38811818 DOI: 10.1038/s41375-024-02292-w  0.396
2018 Nagai K, Hou L, Li L, Nguyen B, Seale T, Shirley C, Ma H, Levis M, Ghiaur G, Duffield A, Small D. Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3. Oncotarget. 9: 32885-32899. PMID 30250637 DOI: 10.18632/Oncotarget.25972  0.451
2016 Ma HS, Greenblatt SM, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Jung E, Aplan PD, Ghiaur G, Jones RJ, Small D. All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo. Blood. PMID 27103744 DOI: 10.1182/Blood-2015-05-646786  0.424
2016 Nagai K, Hou L, Li L, Nguyen B, Shirley CM, Ma HS, Levis MJ, Duffield AS, Small D. Arsenic Trioxide Synergizes with FLT3 Tyrosine Kinase Inhibitors to Kill FLT3-ITD+ Leukemic Cells through Depressed Production and Degradation of FLT3 Protein Blood. 128: 1568-1568. DOI: 10.1182/Blood.V128.22.1568.1568  0.502
2015 Ma HS, McCray ME, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Greenblatt S, Jung E, Aplan PD, Jones RJ, Small D, Ghiaur G. FLT3 Inhibition and Retinoid Signaling Overcome Stromal Protection to Target FLT3/ITD-Expressing Leukemia Stem Cells in the Bone Marrow Microenvironment Blood. 126: 790-790. DOI: 10.1182/Blood.V126.23.790.790  0.434
2014 Kalu NN, Desai PJ, Shirley CM, Gibson W, Dennis PA, Ambinder RF. Nelfinavir inhibits maturation and export of herpes simplex virus 1. Journal of Virology. 88: 5455-61. PMID 24574416 DOI: 10.1128/Jvi.03790-13  0.542
2014 Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. The American Journal of Surgical Pathology. 38: 426-32. PMID 24525514 DOI: 10.1097/Pas.0000000000000128  0.539
2014 Shirley CM, Chu SH, Yang Y, Wright GW, Staudt LM, Small D. Genetic and Pharmacologic Notch4 Inhibition Synergizes with FLT3 Tyrosine Kinase Inhibition in Vitro to More Effectively Eliminate FLT3/ITD-Positive Leukemia Cells Blood. 124: 3583-3583. DOI: 10.1182/Blood.V124.21.3583.3583  0.466
2013 Kalu N, Biswas S, Shirley C, Shamay M, Ambinder RF. Abstract C19: Nelfinavir-induced autophagy and cell death as potential anticancer therapy for KSHV-associated lymphomas. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C19  0.603
2013 Biswas S, Shamay M, Shirley CM, Yonescu R, Matsui WH, Borrello I, Jones RJ, Ambinder RF. Abstract A50: Epstein-Barr virus in the putative stem cell fraction of some multiple myeloma cell lines. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A50  0.495
2012 Kalu N, Shirley C, Ambinder R. ER stress activates lytic gene expression in KSHV-associated tumor cell lines Infectious Agents and Cancer. 7. DOI: 10.1186/1750-9378-7-S1-P33  0.584
2012 Shirley CM, Kalu N, Shamay M, Ambinder RF. Epstein-Barr virus lytic gene expression is tightly linked to ER stress but not cytotoxicity with bortezomib or nelfinavir Infectious Agents and Cancer. 7. DOI: 10.1186/1750-9378-7-S1-P32  0.63
2012 Shirley C, Kalu N, Shamay M, Ambinder RF. Abstract 558: Bortezomib induction of the unfolded protein response mediates Epstein-Barr virus lytic activation but is separable from bortezomib-induced cytotoxicity Cancer Research. 72: 558-558. DOI: 10.1158/1538-7445.Am2012-558  0.609
2011 Shirley CM, Ambinder RF. When differentiation goes viral. Blood. 117: 5790-1. PMID 21636716 DOI: 10.1182/Blood-2011-04-344135  0.574
2011 Shirley CM, Chen J, Shamay M, Li H, Zahnow CA, Hayward SD, Ambinder RF. Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. Blood. 117: 6297-303. PMID 21447826 DOI: 10.1182/Blood-2011-01-332379  0.586
2011 Shirley C, Kalu N, Ambinder RF. Nelfinavir Activates Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus Lytic Cycle by Inducing ER Stress Blood. 118: 5011-5011. DOI: 10.1182/Blood.V118.21.5011.5011  0.594
Show low-probability matches.